Mohamed F Youssef

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Breast Cancer Cells

Tyrosine Kinase

Cell Cycle Arrest

Endoplasmic Reticulum Stress

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Eid E Salama, Mohamed F Youssef, Abouelmagd A, Ahmed T A Boraei, Mohamed S Nafie, Matti Haukka, Assem Barakat, Ahmed A M Sarhan
Discovery of Potent Indolyl-Hydrazones as Kinase Inhibitors for Breast Cancer: Synthesis, X-ray Single-Crystal Analysis, and In Vitro and In Vivo Anti-Cancer Activity Evaluation. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Eid E Salama, Mohamed F Youssef, Abouelmagd A, Ahmed T A Boraei, Mohamed S Nafie, Matti Haukka, Assem Barakat, Ahmed A M Sarhan
Discovery of Potent Indolyl-Hydrazones as Kinase Inhibitors for Breast Cancer: Synthesis, X-ray Single-Crystal Analysis, and In Vitro and In Vivo Anti-Cancer Activity Evaluation. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Eid E Salama, Mohamed F Youssef, Abouelmagd A, Ahmed T A Boraei, Mohamed S Nafie, Matti Haukka, Assem Barakat, Ahmed A M Sarhan
Discovery of Potent Indolyl-Hydrazones as Kinase Inhibitors for Breast Cancer: Synthesis, X-ray Single-Crystal Analysis, and In Vitro and In Vivo Anti-Cancer Activity Evaluation. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Manar G Salem, Sara A Abu El-Ata, Elsherbiny H Elsayed, Suraj Narayan Mali, Hussah Abdullah Alshwyeh, Ghassan Almaimani, Riyad Adnan Almaimani, Hussain A Almasmoum, Najla A Altwaijry, Ebtesam Al-Olayan, Essa M Saied, Mohamed F Youssef
Novel 2-substituted-quinoxaline analogs with potential antiproliferative activity against breast cancer: insights into cell cycle arrest, topoisomerase II, and EGFR activity. RSC advances 13 (47) (2023)
Eid E Salama, Mohamed F Youssef, Abouelmagd A, Ahmed T A Boraei, Mohamed S Nafie, Matti Haukka, Assem Barakat, Ahmed A M Sarhan
Discovery of Potent Indolyl-Hydrazones as Kinase Inhibitors for Breast Cancer: Synthesis, X-ray Single-Crystal Analysis, and In Vitro and In Vivo Anti-Cancer Activity Evaluation. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)